Back to results

TerminatedPhase 2

Safety and Efficacy of EVT 101 in Treatment-Resistant Depression

NCT01128452

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Evotec Study Site 6

Oceanside, California, United States

+13 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2010-06
Enrollment: 8 participants
Sponsor: Janssen Research & Development, LLC
Purpose: treatment

Locations (14)

Evotec Study Site 6Oceanside, California, United States
Evotec Study Site 19San Diego, California, United States
Evotec Study Site 15Tampa, Florida, United States
Evotec Study Site 4Atlanta, Georgia, United States
Evotec Study Site 14Smyrna, Georgia, United States
Evotec Study Site 3Beachwood, Illinois, United States
Evotec Study Site 2Oak Brook, Illinois, United States
Evotec Study Site 1Baltimore, Maryland, United States
Evotec Study Site 8Flowood, Mississippi, United States
Evotec Study Site 5Willingboro, New Jersey, United States
Evotec Study Site 9New York, New York, United States
Evotec Study Site 13Oklahoma City, Oklahoma, United States
Evotec Study Site 7Dallas, Texas, United States
Evotec Study Site 12Houston, Texas, United States

Safety and Efficacy of EVT 101 in Treatment-Resistant Depression — TrialFind